We Produce
More than 100 million people trust our products.
More than 2.500 people of the Zentiva team are working in our Industrial Operations to ensure medicines supply.
We have 4 wholly owned manufacturing sites: Prague (Czech Republic), Bucharest 1, Bucharest 2 (Romania), Ankleshwar (India) and we cooperate with a network of external manufacturing partners.
We produce solids, injectable solutions, eye drops, sterile ointments and hormones, APIs and intermediates with a production of 641,945,041 SMUs (Standard Manufacturing Unit) in 2023.
The sites manufacture more than 70% of Zentiva’s product supply, the balance coming from our network of more than 250 supply partners.
All Sites are driving Sustainability programs, targeting carbon neutrality for Scope 1 and Scope 2 by 2030 and constantly strengthening their efficiency when it comes to energy and electricity, water consumption and waste management.
Our Industrial Network
While the European manufacturing sites are already sourced by 100% renewable energy, we are reaching 60% for our Ankleshwar site in India, and looking for options to further increase this share.
All our sites actively implement a comprehensive Sustainability program. We apply our Suppliers Code of Conduct to every partner and review our third-party cooperations on a regular basis. We operate a highly flexible manufacturing footprint and are well positioned to continue to improve our customer service level across the supply chain. We have ensured the right level of capital investment across our network supporting us in accommodating the volume growth in our mid-term plan.